Rick Doblin's vision of MDMA combined with therapy faces an FDA advisory committee for potential legal medical use after years of shadowy counterculture presence.
MDMA, transformed from its counterculture image, is now a prescription capsule by Lykos Therapeutics with promising regulated studies, despite current Schedule 1 classification by DEA.
[
add
]
[
|
|
...
]